Access Biotechnology has returned for a series B round raised by Eliem Therapeutics, which emerged from stealth with $80m only two months ago.

IDEO-backed cryptocurrency developer Chia Network has pushed its valuation to $500m thanks to a $61m round co-led by Andreessen Horowitz and Richmond Global Ventures.

Exor-backed card issuing technology provider Lithic raised $43m while Mitsui Sumitomo Insurance is providing $36m to lead Upstream Security's series C round.

Undisclosed investors have supplied series D funding for the Sunshine Insurance and Xiaomi-backed bookkeeping and taxation software developer.

Undisclosed investors have supplied series D funding for the Tsinghua-backed bookkeeping and taxation software developer.

BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.

Bristol-Myers Squib and Mount Sinai Innovation Partners have helped the cancer therapeutics developer complete its series B round.

A consortium including Itochu, Fujifilm, Kyocera and Global Power Synergy have backed the lithium-ion battery manufacturer through its series E round.

The UC Berkeley spinout-derived genetic eye disease therapeutics company has launched with fresh funding featuring new and founding investors.

Axa Venture Partners has helped put $60m into Virtuo, while Super collected $50m and Salto picked up $42m.